AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and i…
$0.16+5.42%
报价 2026-11-09
市值
$6.5M
EV
$-5.2M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -89.7%
$0.15$1.59
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| AIMAIM ImmunoTech Inc. | $6.5M | +5.4% | 0.0% | -125.3% | – | – | – | |
| KTTAPasithea Therapeutics Corp. | $18.1M | -6.3% | -100.0% | 0% | – | – | – | |
| QNRXQuoin Pharmaceuticals, Ltd. | $7.8M | +7.0% | – | 0% | – | – | – | |
| SNGXSoligenix, Inc. | $7.4M | +2.0% | 0.0% | 0% | – | – | – | |
| ENSCEnsysce Biosciences, Inc. | $7M | +10.0% | +108.1% | 100% | – | – | – | |
| TCRTAlaunos Therapeutics, Inc. | $5.7M | -4.0% | -84.3% | -28,133.3% | – | – | – | |
| KALAKALA BIO, Inc. | $3.4M | +13.7% | -39.5% | 0% | – | – | – | |
| CANFCan-Fite BioPharma Ltd. | $2.2M | +3.7% | – | 100% | – | – | – | |
| OGENOragenics, Inc. | $1.6M | +1.6% | – | – | – | – | – | |
| 同行中位数 | – | – | -39.5% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。